XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation Plans
9 Months Ended
Sep. 30, 2023
Share-Based Compensation Plans  
Share-Based Compensation Plans

10.  Share-Based Compensation Plans

During the three and nine months ended September 30, 2023, we recognized $321,000 and $996,000, respectively, of compensation expense associated with stock option and restricted stock awards granted in years 2018 through 2023. During the three and nine months ended September 30, 2022, we recognized $339,000 and $1,157,000, respectively, of compensation expense associated with stock option and restricted stock awards granted in years 2017 through 2022.

The following table summarizes our stock option activity for the nine-month period ended September 30, 2023:

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

    

Shares

    

Price

    

Term (Years)

    

Value*

Outstanding at December 31, 2022

 

1,345,369

$

25.83

 

  

 

  

Granted

 

149,200

$

25.79

 

  

 

  

Exercised

 

(404,564)

$

25.36

 

  

 

  

Forfeited or expired

 

(31,890)

$

25.59

 

  

 

  

Outstanding at September 30, 2023

 

1,058,115

$

26.02

 

6.9

$

1,682,000

Exercisable at September 30, 2023

 

609,387

$

26.82

 

5.7

$

1,041,000

*The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of our common stock on September 29, 2023 of $25.35 and the exercise price multiplied by the number of in-the-money outstanding and exercisable stock options.

The following table summarizes our restricted stock award activity for the nine-month period ended September 30, 2023:

Weighted

Weighted

Average

Shares of

Average

Remaining

Aggregate

Restricted

Grant Date

Contractual

Intrinsic

    

Stock

    

Fair Value

    

Term (Years)

    

Value*

Non-vested at December 31, 2022

 

71,808

$

24.67

 

  

 

  

Issued

 

27,700

25.79

 

  

 

  

Vested

 

(28,243)

 

25.65

 

  

 

  

Forfeited

 

(2,175)

 

25.13

 

  

 

  

Non-vested at September 30, 2023

 

69,090

$

25.54

 

2.9

$

1,751,000

*The aggregate intrinsic value of non-vested restricted stock was calculated using the market value of our common stock on September 29, 2023 of $25.35 multiplied by the number of non-vested restricted shares outstanding.